Newsroom

Recent Stories & Press Releases

Articles and press releases are listed in reverse chronological order.

2016

  • Genes That Preserve Health; Genes That Block Cancer Development (September 28, 2016) Highlights the discovery of a ‘modifier gene’ that blocks inflammation thereby protecting against colon cancer despite presence of cancer susceptibility genes and long-term exposure to high-risk diets. Modifier genes that protect against disease have been reported for many birth defects and adult conditions. Here, knowledge of gene function led to testing a small molecule therapeutic that might be used as anti-cancer agent. This work nicely illustrates the ways that such modifier genes might be used in an effective and safe manner to prevent disease. Read more 
  • FenoLogica Biosciences Signs Licensing and Collaboration Agreement with PNRI (September 19, 2016) Company will develop instrumentation and cloud-based analytical tools to accelerate scientific discovery Read more
  • PNRI and Indivumed, GmbH Announce Strategic Collaboration (August 9, 2016) Bioinformatics holds the promise of developing personalized treatment for cancer patients Read more
  • New "Smart Insulin" Technology Acquired by Eli Lilly (February 17, 2016) Read more

2015

  • Jesse Riordan Article Published in Nature's International Journal of Obesity (October 19, 2015) Read more
     
  • David Galas Joins Advisory Committee for National Academies' Institute of Medicine (September 30, 2015) 
  • Read more

  • Students Learn About Research at PNDRI Through Summer Internships (August 18, 2015) PNDRI welcomes Mirutse Heyesus and Tristan Demond
  • Read more
  • Groundbreaking Information Theory Method Seeks Answers in Global Childhood Development Data (April 14, 2015) Grant from Bill & Melinda Gates Foundation Will Fund Analysis.
    Read the press release
  • Dr. Hagopian's Paper Published in DIABETES (January 22, 2015) Non-HLA genes are associated with islet autoantibodies, a marker that reveals the early stages of type 1 diabetes
    Read Hagopian synopsis
  • Dudley Lab Article in the Journal GENETICS (January 8, 2015) Yeast study suggests a protective effect from extra copy of chromosome in diseases caused by a single gene. 
    Read Dudley synopsis

2014

  • Wecker Named Chair of WBBA Board (October 31, 2014) President & CEO, John Wecker, Ph.D., has been appointment chair of the board of Washington Biotechnology & Biomedical Association.
    Read the press release
  • PNDRI Principal Investigator Receives $3.4 Million Award from the NIH (August 4, 2014) Dr. David Galas will lead effort to create new methods to better understand the role of extracellular RNA in humans
    Read the press release
  • PNDRI Announces Partnership with the Accelerator Corporation (July 29, 2014) “At PNDRI, we recognize that collaboration is essential to rapidly transform our scientific breakthroughs into products that can change people’s lives." 
    Read the press release
  • PNDRI President and CEO John Wecker Interviewed by WBBA TV (June 20, 2014) “There is a revolution going on in biology right now that's fueled primarily by rapid advancements in technology and computing power." 
    Watch the interview
  • Endocrine Society Names PNDRI's Dr. Paul Robertson Editor-in-Chief of Journal of Clinical Endocrinology & Metabolism (April 18, 2014) "Yet another reflection of Paul's tremendous scientific and thought leadership contribution over the years."
    Read the press release
     
  • PNDRI Welcomes Two New Board Trustees (March 28, 2014) Former King County Excecutive and Deputy Secretary of the U.S. Department of Housing and Urban Development, Ron Sims, joins PNDRI board
    Read the press release
     
  • PNDRI Principal Investigator Receives $1.4M NIDDK Grant (February 26, 2014) Dr. Joseph Bryan challenges dominant model of insulin release mechanisms
    Read the press release

2013

  • Prominent Yeast Geneticist, Aimée Dudley, Ph.D., Is PNDRI's 8th Principal Investigator (December 4, 2013) Dr. Dudley brings foundational science to strengthen diabetes-focused mission
    Read the press release
  • PNDRI Welcomes Four New Board Trustees to Roster (October 28, 2013) Incoming trustees include Seattle Genetics' co-founder and CEO Clay Siegall 
    Read the press release
     
  • Pacific Northwest Diabetes Research Institute Receives NIH Grant to Study Role of Extracellular RNA in Cell-to-Cell Communication (August 6, 2013) Funding to Dr. Galas and to PNDRI is approximately $2M over five years 
    Read the press release
    Link to the NIH release (will open in new window)

2012

  • Exciting new discovery reported in an article published in PLOS ONE from PNDRI's David Galas, Ph.D.  (12/10/12)
    Molecules from foreign organisms, like bacteria, discovered in normal human blood
    Read a summary from the author
    Read the article (will open in new window)
  • Two New Honorary Trustees Elected  (11/4/12)
    John L. Hutchinson and Karl L. Aschenbach are elected honorary trustees of PNDRI board.
    Read the press release
  • Pacific Northwest Diabetes Research Institute Welcomes World-Renowned Scientists  (9/5/12)
  • David Galas, Ph.D., and Joe Nadeau, Ph.D., join PNDRI to bring critical genetic research programs to help expand the Institute’s long-standing fight against the global diabetes epidemic
    Read the press release
  • Biotechs bring in Flood of New Execs (Puget Sound Business Journal 8/31/12)
    An article about the flood of new executives at local biotech companies, including PNDRI.  
    Read the article (opens on PSBJ site in new window)
    Download the full article (PDF document)
     
  • Patent granted to Pacific Northwest Diabetes Research Institute: Screening Newborns for Genetic Predisposition to Type 1 Diabetes (7/3/12)
    Pacific Northwest Diabetes Research Institute’s has received approval by the U.S. Patent and Trademark Office for its application, Methods for Screening for Genetic Predisposition to Type 1 Diabetes.  Read the Press Release
  • CEO's BLOG: What I Have Learned (5/23/12) 
    It has been one month since I started in my new job here at PNDRI and if there is one word to describe my experience so far, it is “learning.”  I am on one of the steepest learning curves of my professional career...Read more
  • "Study on diabetes in kids shows ‘frightening’ results,” Seattle Times, page one, April 30. The rising prevalence of type 2 diabetes in the general population is alarming. People generally think of a person with type 2 diabetes as middle aged, obese, and inactive. This article underscores the fact that type 2 diabetes can strike people who do not fit the stereotype, including children, those who are lean, and those with an active lifestyle. Read more
  • PNDRI Names John Wecker as new President and CEO  (4/13/12)
    "John's leadership skills and experience in global health are important assets for a future in which diabetes is increasing rapidly in the U.S. and around the world."
    Read the press release

2011

  • An Evening of Wine Raises Record Amount in Support of Diabetes Research (9/27/11)
    A total $311,014 will help advance critical research focused on improved prevention, better treatments and progress toward cures
    Read the press release
  • TEDDY reaches recruitment target, analysis of data to begin (NIDDK newsletter, Summer 2011)
    PNDRI’s partner in the international TEDDY study, the National Institute of Diabetes and Digestive and Kidney Diseases, featured PNDRI’s work
    Read the article (opens on NIDDK site in new window) 
  • PNDRI Announces Impressive List of Winery Partners for Annual Fundraiser (6/1/11)
    An Evening of Wine
    showcases some of the region's top wineries and raises funds for critical diabetes research
    Read the press release 
  • Diabetes in the U.S. (KUOW, 3/8/11)
    Principal Scientist R. Paul Robertson featured on Seattle’s NPR station, during which he discussed the disease, breakthrough research his team is conducting, and the global diabetes tsunami
    Listen to the story (opens on KUOW site in new window) 
  • The Profits of Nonprofit (The Scientist, 1/1/11)
    PNDRI CEO Jack Faris discusses nonprofits and their for-profit business activities
    Read the article (opens on The Scientist site in new window) 

2010

  • Pacific Northwest Diabetes Research Institute launching biotech incubator (Puget Sound Business Journal, 10/14/10)
    Profile of PNDRI’s Urban Innovation Center, created through a grant from the Economic Development Administration
    Read the article (opens on PSBJ site in new window) 
  • Expert in Cell Physiology Joins the Babenko Lab (6/29/10)
    Adrian Sculptoreanu, Ph.D., becomes part of internationally acclaimed collaboration between PNDRI's Babenko and Bryan labs
    Read the press release
  • Mitigating the One-Two Punch of Spinal Cord Injuries (6/10/10)
    Principal Scientist Joe Bryan contributes to promising new strategy that could reduce extent of disability
    Read the press release 

2009

  • PNDRI Appoints New Member to Board of Trustees (11/13/09)
    As the mother of a type 1 diabetic, Lynn Kern brings leadership, fundraising acumen and "spark" to esteemed group 
    Read the press release 
  • PNDRI Scientist Recives $1.7 Million Research Grant from Department of Defense (10/28/09)
    Read the press release 
  • An Evening of Wine Raises More Than $250,000 for Diabetes Research (10/6/09)
    Proceeds from annual fundraiser supports mission of eliminating diabetes and its complications
    Read the press release 
  • Early tests help predict diabetes (Tri-City Herald, 2/9/09)
    PNDRI researchers found indicators for type 1 diabetes in 9-year-old child before she was diagnosed with the disease
    Read the article (opens on Tri-City Herald site in new window) 
  • Internationally Acclaimed Researcher Joins PNDRI as Principal Scientist (10/1/09)
    Andrey Babenko, M.D., Ph.D., becomes the Institute's sixth Principal Scientist 
    Read the press release